ANSUVIMAB

UNII:	TG8IQ19NG2
Formula:
Preferred Substance Name:	ANSUVIMAB

2375952-29-5
ANSUVIMAB [INN]
ANSUVIMAB [USAN]
ANSUVIMAB [WHO-DD]
ANSUVIMAB ZYKL [WHO-DD]
ANSUVIMAB-ZYKL
ANTI-EBOLA MONOCLONAL ANTIBODY MAB114
EBANGA
EBOV MAB114
EVB114
EVB-114
IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN GLYCAN CAP AND GP1 DOMAIN) (HUMAN MONOCLONAL MAB114 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MAB114 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS ENVELOPE GLYCOPROTEIN GP1 SUBUNIT GLYCAN CAP DOMAIN(SUBUNIT (III))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHVV3-13*01 (78%) (IGHD)-IGHJ5*01 (93%)) (8.7.13) (1-119)-HOMO SAPIENS IGHG1*01 (120-449)), (222-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (HOMO SAPIENS IGKV1-27*01 (87%) IGKJ4*01)(6.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-214')), DIMER (228-228'':231-231'')-BISDISULFIDE
MAB114
MAB-114
VRC-EBOMAB092-00-AB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ANSUVIMAB

Synonyms and Mappings

Resources